Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Weiss Steider, Benny ^a   Soto Cruz, Isabel ^a   Martinez Campos, Christian A ^a   Mendoza Rincon, Jorge Flavio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MICA PROTEIN; MICB PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, HUMAN; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN CALO; CELL STRAIN INBL; CELL STRAIN TPH1; CELL STRAIN U937; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; MYELOMONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WESTERN BLOTTING; CULTURE MEDIUM; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; MONOCYTE; MYELOID LEUKEMIA; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKEMIA, MYELOID; MONOCYTES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; UTERINE CERVICAL NEOPLASMS;

EID: 79953737187     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-37     Document Type: Article

References (22)

1. The NKG2D receptor: immunobiology and clinical implications. SJ Burgess K Maasho M Masilamani S Narayanan F Borrego JD Coligan, Immunol Res 2008 40 18 34 10.1007/s12026-007-0060-9 18193361 (Pubitemid 351378033)
2. The role of NKG2D in immunoevasion by tumors and viruses. S Jonjic' B Polic' Krmpotic', Eur J Immunol 2008 38 2927 68 18979520
3. Lysis of a broad range of epithelial tumour cells by human gammadelta T cells: involvement of NKG2D ligands and T-cell receptor-versus NKG2D-dependent recognition. P Wrobel B Shojaei F Schittek B Gieseler H Wollenberg D Kalthoff D Kabelitz D Wesch, Scand J Immunol 2007 66 320 28 10.1111/j.1365-3083.2007.01963. x 17635809 (Pubitemid 47063194)
4. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. A Saez-Borderias M Guma A Angulo B Vellosillo D Pende M Lopez-Botet, Eur J Immunol 2006 36 3198 06 10.1002/eji.200636682 17109473
5. Human MICA and MICB genes: their biological function and relevance to infection and cancer. JF Mendoza-Rincon, Advances in Cancer Research at UNAM Mexico City; Manual Moderno, Mas-Oliva J, Ninomiya-Alarcon J, Garcia-Carranca A, 2007 127 135
6. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B. A Paschen A Sucker B Hill I Moll M Zapatka XD Nguyen GC Sim I Gutmann J Hassel JC Becker A Steinle D Schadendorf S Ugurel, Clin Cancer Res 2009 15 5208 15 10.1158/1078-0432.CCR-09-0886 19671853
7. Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance. AM Unni T Bondar R Medzhitov, Proc Natl Acad Sci USA 2008 105 1686 91 10.1073/pnas.0701675105 18223157 (Pubitemid 351346575)
8. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. NJ Kato J Tanaka T Sugita Y Toubai M Miura Y Ibata Y Syono S Ota T Kondo M Asaka M Imamura, Leukemia 2007 21 2103 08 10.1038/sj.leu.2404862 17625602 (Pubitemid 47423800)
9. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. NJ Chalupny A Rein-Weston S Dosch D Cosman, Biochem Biophys Res Commun 2006 346 175 81 10.1016/j.bbrc.2006.05.092 16750166 (Pubitemid 43865981)
10. Variation in MICA and MICB genes and enhanced susceptibility to paucibacillary leprosy in South India. K Tosh M Ravikumar JT Bell S Meisner AV Hill R Pitchappan, Hum Mol Genet 2006 15 2880 87 10.1093/hmg/ddl229 16923796 (Pubitemid 44446808)
11. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. A Santoni A Zingoni C Cerboni A Gismongi, Am J Reprod Immunol 2007 58 280 88 10.1111/j.1600-0897.2007.00513.x 17681044 (Pubitemid 47249066)
12. Involvement of NK cells against tumors and parasites. M Papazahariadou GI Athanasiadis E Papadopoulos I Symeonidou M Hatzistilianou ML Castellani K Bhattacharya LN Shanmugham P Conti S Frydas, Int J Biol Markers 2007 22 144 53 17549670 (Pubitemid 47062219)
13. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. HR Salih D Goehlsdorf A Steinle, Hum Immunol 2006 67 188 95 10.1016/j.humimm.2006.02.008 16698441 (Pubitemid 43673929)
14. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity. A Marten M von Lilienfeld-Toal MW Buchler J Schmidt, Int J Cancer 2006 119 2359 65 10.1002/ijc.22186 16929491 (Pubitemid 44546956)
15. Soluble NKG2D ligands: prevalence, release and functional impact. HR Salih S Holdenrieder A Steinle, Front Biosci 2008 4A 2041 45
16. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA. S Holdenrieder P Stieber A Peterfi D Nagel A Steinle HR Salih, Cancer Immunol Immunother 2006 55 1584 89 10.1007/s00262-006- 0167-1 16636811 (Pubitemid 44327846)
17. Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions. L Rocha-Zavaleta JP Ambrosio L Mora-Garcia Mde F Cruz-Talonia J Hernandez-Montes B Weiss-Steider V Ortiz-Navarrete A Monroy-Garcia, J Gen Virol 2004 85 2643 50 10.1099/vir.0.80077-0 15302958 (Pubitemid 39214360)
18. Identification of two homologous antigenic peptides derived from L1 HPV-16 and 18 proteins specific for the HLA-B*3901 allele. A Monroy-Garcia B Weiss-Steider J Hernandez-Montes VF Ortiz-Navarrete A Banuelos-Panuco A Acosta-Araujo A Diaz-Quinonez CM Lopez-Graniel G Herbert J Granados C deLeo RM Silvia-Lopez ML Mora-García, Arch Virol 2002 147 1933 42 10.1007/s00705-002-0854-y 12376754 (Pubitemid 35218717)
19. NKG2D and Natural Cytotoxicity Receptors Are Involved in Natural Killer Cell Interaction with Self-Antigen Presenting Cells and Stromal Cells. A Paggi C Prevosto M Zancolli P Canevalli A Musso MR Zocchi, Ann N Y Acad Sci 2007 1109 47 57 10.1196/annals.1398.007 17785290 (Pubitemid 47511344)
20. Regulation of ligands for the activating receptor NKG2D. AR Mistry CA O'Callaghan, Immunology 2007 121 439 47 10.1111/j.1365-2567.2007.02652.x 17614877 (Pubitemid 47030096)
21. The expression of human natural killer cell receptors in early life. Y Sundstrom C Nilsson K Karre M Troye-Blomberg L Berg, Scand J Immunol 2007 266 335 44 10.1111/j.1365-3083.2007.01980.x (Pubitemid 47063206)
22. Comparison of level of NKG2D ligands between normal and tumor tissue using multiplex RT-PCR. SW Park JH Bae SD Kim YO Son JY Kim HJ Park CH Lee DY Park JY Kim MK Lee BS Cheng SH Kim CD Kang, Cancer Invest 2007 25 299 07 10.1080/07357900701208824 17661204